{
    "code": "12002569",
    "time": "2015-07-24 06:12:52",
    "許可證字號": "內衛藥製字第002569號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "59\/04\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "",
    "中文品名": "惠樂平注射液",
    "英文品名": "PHETROPIN INJECTION",
    "適應症": "癲癇",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "D第四級管制藥品",
    "主成分略述": "ATROPINE SULFATE, CAFFEINE SODIUM BENZOATE, PHENOBARBITAL",
    "限制項目": [
        "01國產",
        "09委託製造",
        "1G不得製造",
        "34第四級管制藥品"
    ],
    "申請商名稱": "6221040522  大安化學製藥股份有限公司",
    "申請商地址": "台南市北區勝利路473號",
    "主製造廠": {
        "製造廠名稱": "0306811300  大豐製藥股份有限公司",
        "製造廠廠址": "彰化市延平里岸頭巷１１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208000530",
            "成分名稱": "ATROPINE SULFATE",
            "含量描述": "",
            "含量": "0.2500000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000420",
            "成分名稱": "CAFFEINE SODIUM BENZOATE",
            "含量描述": "",
            "含量": "30.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2824401200",
            "成分名稱": "PHENOBARBITAL",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 內衛藥製字第02569號-2013-12-31.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=12002569&Seq=001&Type=9"
        }
    ]
}